Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...
Update 3:10pm: Adds analyst comment. Regeneron (NASDAQ:REGN) won a permanent injunction that blocks drugmakers including, ...
White, Lucy. "Mylan Lab's Proposed Merger with King Pharmaceuticals—courseware." Harvard Business School Spreadsheet Supplement 214-709, May 2014. (Revised June 2016.) ...
Hosted on MSN19d
Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan Pharmaceuticalsto enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited (“Mylan”) for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane,” the ...
In this edition of The Precedent, we outline the decision in Regeneron Pharms., Inc. v. Mylan Pharms. Inc. In Regeneron Pharms., Inc. v. Mylan ...
Novartis’ Sandoz generics arm, and Hikma have tried unsuccessfully to get copies approved, and the regulator had rejected Mylan’s generic last summer. However the regulator said at the time ...
Pfizer Ltd entered into a marketing and supply agreement with Mylan Pharmaceuticals Private Limited to market and supply its two significant revenue contributors, Ativan and Pacitane ...
The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback